FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3213095 · Received July 9, 2013

Report

Report Number
2124215-2013-10615
Event Type
Malfunction
Date Received
July 9, 2013
Date of Event
June 5, 2013
Report Date
June 6, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

--

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT'S HOME MONITORING EQUIPMENT DETECTED A HIGH OUT OF RANGE SHOCKING IMPEDANCE FOR THIS PATIENT'S RIGHT VENTRICULAR (RV) LEAD. IT WAS DETERMINED THAT THE PATIENT WAS UNDERGOING A TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) PROCEDURE DURING THE TIME OF THE OUT-OF-RANGE (OOR) MEASUREMENT. TO DATE, NO ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
314415 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 63 YR 0185| 4470| E110